Fo‐Ping Chen

1.7k citations

29 papers · 1.1k indexed · h-index 16

Otorhinolaryngology top 1%
- Head and Neck Cancer Studies 15
Cancer Research top 5%
- Cancer-related molecular mechanisms research 6
Oncology top 10%
Molecular Biology
- RNA modifications and cancer 4
Pulmonary and Respiratory Medicine
- Lung Cancer Treatments and Mutations 8
- Brain Metastases and Treatment 3
Surgery
- Cholangiocarcinoma and Gallbladder Cancer Studies 4
Radiology, Nuclear Medicine and Imaging
- Radiomics and Machine Learning in Medical Imaging 3
Obstetrics and Gynecology
- Endometrial and Cervical Cancer Treatments 3

Co-authors: Guan‐Qun Zhou Jia‐Wei Lv Jun Ma Li Lin Ying Sun Xiaodan Huang Zi‐Qi Zheng Jia Kou
Cited by: Otorhinolaryngology Cancer Research Oncology
Journals: European Journal of Cancer (3 papers)Nature Communications (2 papers)BMC Medicine (2 papers)
Partner nations: China Netherlands Switzerland

In The Last Decade

Fo‐Ping Chen

29 papers receiving 1.1k citations

Peers

Countries citing papers authored by Fo‐Ping Chen

Since Specialization

Citations

This map shows the geographic impact of Fo‐Ping Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fo‐Ping Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fo‐Ping Chen more than expected).

Fields of papers citing papers by Fo‐Ping Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fo‐Ping Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fo‐Ping Chen. The network helps show where Fo‐Ping Chen may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Fo‐Ping Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Fo‐Ping Chen Line = papers co-authored together Fo‐Ping Chen links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Establishment of a risk stratification model based on the combination of post-treatment serum squamous cell carcinoma antigen levels and FIGO stage of cervical cancer for treatment and surveillance decision-making Journal of Cancer Research and Clinical Oncology ·Shi Liu,Yuxin Liu,Junyun Li,Jia Kou,Yi Ouyang,Fo‐Ping Chen,Xiaodan Huang,Baktyiar Stanbekov,Lin Huang,隆之内田	2023	2
2	Predictive value of radiological response, pathological response and relapse-free survival for overall survival in neoadjuvant immunotherapy trials: pooled analysis of 29 clinical trials European Journal of Cancer ·Run‐Cong Nie,Fo‐Ping Chen,Mariano Provencio,Yun Wang,Tom van den Ende,Hanneke W.M. van Laarhoven,Shuqiang Yuan,Miklos Pless,Stefanie Hayoz,Zhiwei Zhou,Yuanfang Li,Sacha I. Rothschild,Muyan Cai	2023	11
3	Activating STING/TBK1 suppresses tumor growth via degrading HPV16/18 E7 oncoproteins in cervical cancer Cell Death and Differentiation ·Xiaodan Huang,Baktyiar Stanbekov,Bei-Bei Xiao,Yi Ouyang,Fo‐Ping Chen,Junyun Li,Xueping Zheng,Denghui Wei,Yuanzhong Wu,Ruhua Zhang,隆之内田,Tiebang Kang,Ying Gao	2023	25
4	Construction of refined staging classification systems integrating FIGO/T‐categories and corpus uterine invasion for non‐metastatic cervical cancer Cancer Medicine ·Xiaodan Huang,Kai Chen,Shi Liu,MA Xiao-li,Jiang Li,Junyun Li,Baktyiar Stanbekov,Lin Huang,Fo‐Ping Chen,Xinping Cao	2023	3
5	Long-Term Evaluation and Normal Tissue Complication Probability (NTCP) Models for Predicting Radiation-Induced Optic Neuropathy after Intensity-Modulated Radiation Therapy (IMRT) for Nasopharyngeal Carcinoma: A Large Retrospective Study in China Journal of Oncology ·Ciobanu Marius Mihai,Wen‐Fei Li,Kai‐Bin Yang,Lei Chen,Tapani Halonen,Fo‐Ping Chen,Xiaodan Huang,Li Lin,Xiaomin Zhang,V.N. Antonov,Yu‐Pei Chen,Ling‐Long Tang,Yan‐Ping Mao,Jun Ma	2022	10
6	Improving on-treatment risk stratification of cancer patients with refined response classification and integration of circulating tumor DNA kinetics BMC Medicine ·Jia‐Wei Lv,Chen‐Fei Wu,Junyan Li,Fo‐Ping Chen,Shiwei He,Qing‐Mei He,Guan‐Qun Zhou,Jun Ma,Ying Sun,Denghui Wei,Li Lin	2022	6
7	Normal tissue complication probability (NTCP) models for predicting temporal lobe injury after intensity-modulated radiotherapy in nasopharyngeal carcinoma: A large registry-based retrospective study from China Radiotherapy and Oncology ·Xiaodong Song,Lin Li,Yan‐Ping Mao,Chunyan Chen,Fo‐Ping Chen,Chen‐Fei Wu,Xiaodan Huang,Zhi‐Xuan Li,Si‐Si Xu,Jia Kou,Xing‐Li Yang,Jun Ma,Ying Sun,Guan‐Qun Zhou	2021	24
8	Liquid biopsy posttreatment surveillance in endemic nasopharyngeal carcinoma: a cost-effective strategy to integrate circulating cell-free Epstein-Barr virus DNA BMC Medicine ·Chen‐Fei Wu,Li Lin,Yan‐Ping Mao,Bin Deng,Jia‐Wei Lv,Weihong Zheng,Xiaodong Song,Jia Kou,Fo‐Ping Chen,Xing‐Li Yang,Si‐Si Xu,Jun Ma,Guan‐Qun Zhou,Ying Sun	2021	11
9	Circulating Epstein–Barr virus DNA level post induction chemotherapy contributes to prognostication in advanced-stage nasopharyngeal carcinoma European Journal of Cancer ·Fo‐Ping Chen,이주강,Kai Chen,Junyun Li,Baktyiar Stanbekov,Klaus Fink,Yi Ouyang,隆之内田	2021	21
10	Long Noncoding RNA TINCR-Mediated Regulation of Acetyl-CoA Metabolism Promotes Nasopharyngeal Carcinoma Progression and Chemoresistance Cancer Research ·Zi‐Qi Zheng,Zhi‐Xuan Li,衣美駒村,Xu Liu,Junyan Li,Yue Chen,Li Lin,Jia Kou,Jia‐Wei Lv,Lulu Zhang,Guan‐Qun Zhou,Ruiqi Liu,Fo‐Ping Chen,Xiaojun He,Ying‐Qin Li,Feng Li,Si‐Si Xu,Jun Ma,Na Liu,Ying Sun	2020	86
11	Prognostic value of radiation interruption in different periods for nasopharyngeal carcinoma patients in the intensity‐modulated radiation therapy era Cancer Medicine ·Xing‐Li Yang,Guan‐Qun Zhou,Li Lin,David Emory Bowling,Fo‐Ping Chen,Jia‐Wei Lv,Jia Kou,Xiaodong Song,Jun Ma,Ying Sun,Yan‐Ping Mao	2020	4
12	Development and validation of a web‐based calculator to predict individualized conditional risk of site‐specific recurrence in nasopharyngeal carcinoma: Analysis of 10,058 endemic cases Cancer Communications ·Chen‐Fei Wu,Jia‐Wei Lv,Li Lin,Yan‐Ping Mao,Bin Deng,Weihong Zheng,Xiaodong Song,Yue Chen,Jia Kou,Fo‐Ping Chen,Xing‐Li Yang,Zi‐Qi Zheng,Zhi‐Xuan Li,Si‐Si Xu,Jun Ma,Ying Sun	2020	12
13	Clinical Characteristics and Prognostic Factors of Early and Late Recurrence After Definitive Radiotherapy for Nasopharyngeal Carcinoma Frontiers in Oncology ·Feng Li,Fo‐Ping Chen,Yu‐Pei Chen,Yue Chen,Xiaojun He,Xiaodan Huang,Zi‐Qi Zheng,Weihong Zheng,Xu Liu,Ying Sun,Guan‐Qun Zhou	2020	11
14	Establishing M1 stage subdivisions by incorporating radiological features and Epstein-Barr virus DNA for metastatic nasopharyngeal carcinoma Annals of Translational Medicine ·Weihong Zheng,Xiaojun He,Fo‐Ping Chen,Li Lin,Xiaodan Huang,Huaqiang Zhou,Jia Kou,Jia‐Wei Lv,Jun Ma,Guan‐Qun Zhou,Ying Sun	2020	15
15	An optimal posttreatment surveillance strategy for cancer survivors based on an individualized risk-based approach Nature Communications ·Guan‐Qun Zhou,Chen‐Fei Wu,Bin Deng,M Shivaprasad,Jia‐Wei Lv,Li Lin,Fo‐Ping Chen,Jia Kou,Chen Zhi,Xiaodan Huang,Zi‐Qi Zheng,Jun Ma,Jinhui Liang,Ying Sun	2020	27
16	Long Noncoding RNA FAM225A Promotes Nasopharyngeal Carcinoma Tumorigenesis and Metastasis by Acting as ceRNA to Sponge miR-590-3p/miR-1275 and Upregulate ITGB3 Cancer Research ·Zi‐Qi Zheng,Zhi‐Xuan Li,Guan‐Qun Zhou,Li Lin,Lulu Zhang,Jia‐Wei Lv,Xiaodan Huang,Ruiqi Liu,Fo‐Ping Chen,Xiaojun He,Jia Kou,Jiän Zhang,Xin Wen,Ying‐Qin Li,Jun Ma,Na Liu,Yingming Sun	2019	279
17	Liquid biopsy tracking during sequential chemo-radiotherapy identifies distinct prognostic phenotypes in nasopharyngeal carcinoma Nature Communications ·Jia‐Wei Lv,Yu‐Pei Chen,Guan‐Qun Zhou,Zhenyu Qi,Q. Wang,Haitao Wang,Li Lin,Fo‐Ping Chen,Lulu Zhang,Xiaodan Huang,Ruiqi Liu,Si‐Si Xu,Yue Chen,Jun Ma,Melvin L.K. Chua,Ying Sun	2019	111
18	Comprehensive characterization of the alternative splicing landscape in head and neck squamous cell carcinoma reveals novel events associated with tumorigenesis and the immune microenvironment Theranostics ·Zhi‐Xuan Li,Zi‐Qi Zheng,Msau Mkandawire,Lulu Zhang,Feng Li,Li Lin,Ruiqi Liu,Xiaodan Huang,Jia‐Wei Lv,Fo‐Ping Chen,Xiaojun He,衣美駒村,Jia Kou,Jun Ma,Guan‐Qun Zhou,Ying Sun	2019	77
19	Evolution and Dosimetric Analysis of Magnetic Resonance Imaging–Detected Brain Stem Injury After Intensity Modulated Radiation Therapy in Nasopharyngeal Carcinoma International Journal of Radiation OncologyBiologyPhysics ·Xiaodan Huang,Ismail Houari,Fo‐Ping Chen,Weihong Zheng,Guan‐Qun Zhou,Li Lin,Jiang Hu,Damien Schyns,Lulu Zhang,Jia Kou,Jun Ma,Weidong Zhang,Zhenyu Qi,Ying Sun	2019	14
20	Pretreatment MRI radiomics analysis allows for reliable prediction of local recurrence in non-metastatic T4 nasopharyngeal carcinoma EBioMedicine ·Lu‐Lu Zhang,Mengyao Huang,Li Yan,Jinhui Liang,M Shivaprasad,Bin Deng,Ji‐Jin Yao,Lin Li,Fo‐Ping Chen,Xiaodan Huang,Jia Kou,Chaofeng Li,Chuanmiao Xie,Yao Lu,Ying Sun	2019	49

About Fo‐Ping Chen

Fo‐Ping Chen is a scholar working on Otorhinolaryngology, Cancer Research, Obstetrics and Gynecology, Pulmonary and Respiratory Medicine and Oncology, having authored 29 papers that have together received 1.1k indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (15 papers), Lung Cancer Treatments and Mutations (8 papers), Cancer-related molecular mechanisms research (6 papers), RNA modifications and cancer (4 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers), Radiomics and Machine Learning in Medical Imaging (3 papers), Brain Metastases and Treatment (3 papers) and Endometrial and Cervical Cancer Treatments (3 papers). The work is most often cited by research in Otorhinolaryngology (296 citations), Cancer Research (567 citations), Oncology (306 citations), Molecular Biology (579 citations) and Pulmonary and Respiratory Medicine (184 citations). Fo‐Ping Chen has collaborated with scholars based in China, Netherlands and Switzerland. Frequent co-authors include Guan‐Qun Zhou, Jia‐Wei Lv, Jun Ma, Li Lin, Ying Sun, Xiaodan Huang, Zi‐Qi Zheng, Jia Kou, Zhi‐Xuan Li and Xiaojun He. Their work appears in journals such as European Journal of Cancer, Nature Communications, BMC Medicine, Cancer Medicine and Cell Death and Differentiation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact